FibrilaciónApp on Windows Pc

The application intuitively leads us on an algorithm for the management of oral anticoagulation in patients with AF, begins to touch the atrial fibrillation icon showing an example of this in a simple way for identification.
Then the algorithm separates the valvular AF Nonvalvular and touch the icon valvular AF, the definition appears accepting what is considered as valvular AF, and then being as a definition of non-valvular AF everything that is not covered under the definition of valvular AF.

Icon valvular AF, the application will take you to the absolute indication for anticoagulation with warfarin. Then by clicking on the icon warfarin, this sends it to determine a risk score SAMeTT2R2 score that assesses the likelihood that the patient has a greater chance of achieving the greatest time in therapeutic range (TRT) as follows: If the patient has a score of SAMeTT2R2 score <2, this suggests that the patient will have a greater chance of reaching a time in therapeutic range (TRT)> 65%; but if the value of SAMeTT2R2 score is> 2 these patients would be less likely to achieve, and therefore more intensive management or anticoagulation clinic surveillance and closer monitoring would be recommended. After SAMeTT2R2 calculated, which is within the application, the algorithm will take the recommendation of appropriate INR for patients with FA. (INR between 2.0 and 3.0).

If the patient has non-valvular AF, the click on that icon, will direct evaluate the CHA2DS2-VASc indicating that patient does not require any anti-aggregation and anticoagulation (CHA2DS2-VASc = 0). The score also inform us the annual risk of stroke (ischemic cardioembolic stroke). The indication and evidence of the use of this score is included in the app. After this calculation the app will direct you to the risk assessment of bleeding with HAS-BLED (also built-in app), and the result is presented as low-risk or high risk of bleeding as well: If the HAS-BLED is> 3 high risk of bleeding that is not a contraindication for anticoagulation and modify only identified risk factors. In the app there is also additional list of risk factors for bleeding used in other risk scores.

After the HAS-BLED, the app takes you to the value of CHA2DS2-VASc that calculation and make a recommendation for anticoagulation or not. Men oral anticoagulation if CHA2DS2-VASc> 1 and for women if CHA2DS2-VASc> 2. Definite indication of anticoagulation the app runs to calculate creatinine clearance by the Cockcroft-Gault (It is also located within the app). Along with the evidence supporting this indication. If the calculation of creatinine clearance is> 30 mL / min, the app will take to consider using direct oral anticoagulants (ACOD) [apixaban, rivaroxaban or dabigatran]. A preference treating physician.
And when you click on any of the ACOD, the specific information based on the results of their clinical trial molecule, and the recommended dose is displayed.

Now if creatinine clearance calculated is <30 mL / min, the app will take you to indicate anticoagulation FA patient alone with warfarin, with the proviso that apixaban could be used if creatinine clearance is> 25 mL / min.

Allows applications to open network sockets.